Health Canada is advising Canadians of a U.S. Food and Drug Administration (FDA) warning not to use dietary supplements labeled as “OxyElite Pro” following several U.S. reports of serious liver injury. Certain OxyElite Pro dietary supplements are being recalled by the distributor, USPLabs LLC of Dallas, Texas.
OxyElite Pro products, which are promoted for rapid weight loss, are not authorized in Canada and have not been found on the Canadian market. However, they are widely available in the U.S. and over the Internet. Canadians may have purchased these products while shopping online or travelling. To date, no adverse reactions have been reported to Health Canada involving OxyElite Pro.
Several dozen U.S. cases of liver damage have so far been potentially linked to OxyElite Pro, including at least one case resulting in a liver transplant, and one death. Symptoms of liver injury can include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay or gray-colored bowel movements, joint pain, yellow eyes, and jaundice.
The U.S. FDA and the Centre for Disease Control are continuing their investigation regarding OxyElite and the reports of hepatic adverse reactions.
For further details and affected products, please refer to the following link:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../36785a-eng.php
In Hong Kong, the above products are not registered pharmaceutical products. Related news has been released by FDA, HSA and MHRA and was posted on the Drug Office website on 9 October, 15 October, 19 October, 9 November and 11 November 2013. A press release was issued to appeal the public not to buy or use oral product labeled as OxyELITE Pro on 9 October 2013.
Ends/ Saturday, November 16, 2013
Issued at HKT 12:00
|
